Use of non-vitamin K antagonists oral anticoagulants in atrial fibrillation patients on dialysis

BACKGROUND: Non-vitamin K antagonist oral anticoagulants (NOACs) showed a benefit-risk profile superior to that of warfarin in atrial fibrillation (AF) patients with mild to moderate chronic kidney disease. However, the effectiveness and safety of NOACs in AF patients with end-stage renal disease (E...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Wenhao, Zhou, Yanxia, Chen, Siqi, Zeng, Dewang, Zhang, Haidong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513185/
https://www.ncbi.nlm.nih.gov/pubmed/36176998
http://dx.doi.org/10.3389/fcvm.2022.1005742

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513185/
https://www.ncbi.nlm.nih.gov/pubmed/36176998
http://dx.doi.org/10.3389/fcvm.2022.1005742

Ejemplares similares